Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof
A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
1. A pharmaceutical composition for treating degenerative diseases of mammals, said pharmaceutical composition comprising:
a pharmaceutical carrier including at least one of a gel, a cream, a spray, a patch; and
a chemical compound including at least one oxide, sulfate, citrate, gluconate, or chelate whereby each of said oxide, sulfate, citrate, gluconate, or chelate includes a chemical element with isotope ratio different, from natural abundance and enriched with at least one of light isotopes K-39, Mg-24, Zn-64, Rb-85, Si-26, Ca-40, Cu-63, Fe-54, Cr-52, Ni-58, Mo-92, Ag-107, Br-79, and Cl-35 or a combination thereof, whereby said chemical compound containing at least one of said light isotopes in pharmaceutical carrier ranges from 0.1% to 99.9% of the total weight of the composition to achieve therapeutic effect on the mammal.
2. The pharmaceutical composition as set forth in claim 1 , wherein chemical elements and chemical compounds are food supplements.
3. The pharmaceutical composition of claim 1 , wherein the at least one oxide, sulfate, citrate, gluconate, or chelate includes zinc with isotope ratio different from natural abundance and enriched with Zn-64.
4. The pharmaceutical composition of claim 1 , wherein the at least one oxide, sulfate, citrate, gluconate, or chelate includes silicon with isotope ratio different from natural abundance and enriched with Si-26.
5. The pharmaceutical composition of claim 1 , wherein the at least one oxide, sulfate, citrate, gluconate, or chelate includes magnesium with isotope ratio different from natural abundance and enriched with Mg-24.